Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (LYRA)

CUSIP: 55234L105

Q2 2025 13F Holders as of 30 Jun 2025

Security identity
Security type / class
Equity / Common Stock, $0.001 par value
Shares outstanding
1,644,695
Holder snapshot
Total 13F shares
300
Share change
-25,350,000
Total reported value
$26
Reported price per share
$0.09
Number of holders
1
Value change
-$3,198,074
Number of buys
1
Number of sells
54

Security key

55234L105

Report period

Q2 2025

Institutions

1

Top holders

1

LYRA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Lyra Therapeutics, Inc. SEC filings Lyra Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of LYRA - Lyra Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Nantahala Capital Managem...
13D/G signal
Nantahala Capital Managem...
Evidence rows
15
Latest as of
31 Mar 2025
13D/G 13F Lead comparable stake: 1.1% 13D/G row: Nantahala Capital Management, LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Nantahala Capital Management, LLC
13D/G
13D/G
1.1%
$84,253
702,106 shares
 $0 30 Sep 2024
PERCEPTIVE ADVISORS LLC
13F
Company
13F
776%
$1,607,453
12,757,562 shares
 — 31 Mar 2025
BlackRock, Inc.
13F
Company
13F
184%
$381,298
3,018,986 shares
 — 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13F
107%
$222,464
1,765,585 shares
 — 31 Mar 2025
Samsara BioCapital, LLC
13F
Company
13F
85%
$175,573
1,390,130 shares
 — 31 Mar 2025
Ikarian Capital, LLC
13F
Company
13F
64%
$133,645
1,058,148 shares
 — 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
300
Rows available
1
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
55
Q2 2025 holders
1
Holder diff
-54
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 value Q2 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .